Diabetes: DPP-4 inhibitors reduce risk for AKI

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Treatment with dipeptidyl peptidase 4 (DPP-4) inhibitors reduces the risk for acute kidney injury (AKI) in patients with diabetes mellitus (DM).

Why this matters

  • Prior studies reporting a renoprotective effect have mainly focused on albuminuria.

Study design

  • Prospec...